Biocon Gets DCGI Nod for Emergency Use of Itolizumab for Treatment of Covid-19 Patients

Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe COVID-19 complications, it added.

from Top Business News- News18.com https://ift.tt/2W8BC3i
via IFTTT